{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"55","upperLimit":"87","value":"75"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"28"}],"units":"Participants"}],"description":"Estimated Day 56 survival rate following initiation of etanercept + corticosteroid therapy for patients with IPS.","dispersionType":"95% Confidence Interval","groups":[{"description":"Regimen A","id":"OG000","title":"Etanercept and Corticosteroid Therapy"}],"paramType":"NUMBER","populationDescription":"Analysis population includes all patients who are eligible and had sufficient data to evaluate response. Eleven ineligible patients are excluded.","reportingStatus":"POSTED","timeFrame":"Up to day 56","title":"Survival Rate","type":"SECONDARY","unitOfMeasure":"percentage of participants"}